Head of FCPiLO Elena Maksimkina: Increasing the efficiency of health spending in the current difficult economic conditions requires, first of all, the elimination of the "gaps" in the supply of medicines "If we talk about changing health care financing models, then first of all we need to eliminate the deficiencies in the financing of medical treatment", she stated in the "Efficiency Code: Financial Models that Determine the Future of the Health System" session at the "Right to Health" Congress. On the centralization of procurement, redistribution and reimbursement of medicines: According to Elena Maximina, it is desirable to maintain government procurement and funding of medical treatment at the federal level, mainly for patients with orphan diseases. One of the main advantages is the ability to redistribute drugs centrally as needed. According to its data, over the past 5 years, costs for orphan patients have increased 2.4 times - today the federal center manages purchases of more than 280 billion rubles. And the redistribution of medicines made it possible to save 13 billion rubles of budget money. Therefore, it proposed to remove the existing regulatory restrictions preventing the redistribution of drugs that have already been purchased or imported. We are talking about drugs that are purchased for a specific patient, as well as drugs, the continued use of which is limited by the peculiarities of regional financing or the conditions of purchase and delivery. In addition to orphan diseases, the centralized procurement shows effectiveness for special programs - for example in oncology, diabetes treatment, bronchial asthma, HIV infection, hepatitis as well as within the national preventive vaccination schedule. For other areas, Maximina sees the need to move in the direction of a medication reimbursement system - reimbursement of the cost of medications that patients receive through pharmacies. This is where insurance companies can play an important role.

Head of FCPiLO Elena Maksimkina: Increasing the efficiency of health spending in the current difficult economic conditions requires, first of all, the elimination of the "gaps" in the supply of medicines "If we talk about changing health care financing models, then first of all we need to eliminate the deficiencies in the financing of medical treatment", she stated in the "Efficiency Code: Financial Models that Determine the Future of the Health System" session at the "Right to Health" Congress. On the centralization of procurement, redistribution and reimbursement of medicines: According to Elena Maximina, it is desirable to maintain government procurement and funding of medical treatment at the federal level, mainly for patients with orphan diseases. One of the main advantages is the ability to redistribute drugs centrally as needed. According to its data, over the past 5 years, costs for orphan patients have increased 2.4 times - today the federal center manages purchases of more than 280 billion rubles. And the redistribution of medicines made it possible to save 13 billion rubles of budget money. Therefore, it proposed to remove the existing regulatory restrictions preventing the redistribution of drugs that have already been purchased or imported. We are talking about drugs that are purchased for a specific patient, as well as drugs, the continued use of which is limited by the peculiarities of regional financing or the conditions of purchase and delivery. In addition to orphan diseases, the centralized procurement shows effectiveness for special programs - for example in oncology, diabetes treatment, bronchial asthma, HIV infection, hepatitis as well as within the national preventive vaccination schedule. For other areas, Maximina sees the need to move in the direction of a medication reimbursement system - reimbursement of the cost of medications that patients receive through pharmacies. This is where insurance companies can play an important role.